Fig. 6
From: Individualized prediction tool for patients with metastatic gastric signet cell carcinoma
Kaplan–Meier survival analyses for comparing postoperative overall survival in the low risk, middle risk, and high risk subgroups of all patients in the training cohort (A) and validation cohort (B).
